Anna Protopapas
2019
Compensation breakdown
Non-Equity Incentive Plan | $293,150 |
---|---|
Option Awards | $506,645 |
Salary | $533,000 |
Stock Awards | $400,000 |
Other | $7,000 |
Total | $1,739,795 |
Protopapas received $533K in salary, accounting for 31% of the total pay in 2019.
Protopapas also received $293.2K in non-equity incentive plan, $506.6K in option awards, $400K in stock awards and $7K in other compensation.
Rankings
In 2019, Anna Protopapas' compensation ranked 6,598th out of 13,971 executives tracked by ExecPay. In other words, Protopapas earned more than 52.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,598 | 53rd |
Manufacturing | 2,507 | 56th |
Chemicals And Allied Products | 909 | 59th |
Drugs | 769 | 59th |
Pharmaceutical Preparations | 564 | 60th |
Protopapas' colleagues
We found four more compensation records of executives who worked with Anna Protopapas at Mersana Therapeutics in 2019.
2019
Dirk Huebner
Mersana Therapeutics
Chief Medical Officer
2019
Brian DeSchuytner
Mersana Therapeutics
Senior Vice President, Finance & Product Strategy
2019
Timothy Lowinger
Mersana Therapeutics
Chief Science and Technology Officer
2019
Michael Kaufman
Mersana Therapeutics
Chief Manufacturing Officer
News
April 26, 2024
April 28, 2023
April 29, 2022
April 27, 2021
April 20, 2020
April 23, 2019